Y染色体嵌合缺失与冠状动脉造影后死亡率
在1698例接受冠状动脉造影的男性LURIC研究参与者中,Y染色体嵌合缺失(LOY)在60岁时急剧增加;LOY>17%与全因死亡和心血管死亡风险显著升高相关,且由致命性心肌梗死风险驱动,并伴随促纤维化促炎血浆蛋白谱。
要点
- LOY>17%与全因死亡(HR 1.41)和心血管死亡(HR 1.49)风险升高独立相关。
- 致命性心肌梗死风险在LOY>17%者中显著升高(HR 2.65)。
- 遗传易感性低心肌纤维化可减弱LOY与心血管死亡的关联。
核心结论
- LOY是男性冠心病患者心血管死亡的独立危险因素,靶向LOY可能成为性别特异性个体化治疗途径。
研究设计与样本
- LURIC研究纳入1698例接受冠状动脉造影的男性参与者,量化LOY并分析其与全因及心血管死亡的关系。
主要发现
- LOY频率在60岁时急剧增加;LOY>17%与全因死亡(HR 1.41,95%CI 1.09-1.82)和心血管死亡(HR 1.49,95%CI 1.09-2.03)风险升高相关。
- LOY>17%与致命性心肌梗死风险升高相关(HR 2.65,95%CI 1.46-4.81)。
- LOY>17%伴随促纤维化促炎血浆蛋白谱,包括骨保护素、MMP-12、GDF-15、HB-EGF和抵抗素水平升高。
- 遗传易感性低心肌纤维化减弱LOY与心血管死亡的关联;全基因组甲基化分析发现298个基因差异甲基化,单细胞RNA测序确认37个基因差异表达。
临床怎么用
- 在男性冠脉造影患者中,LOY>17%可作为心血管死亡风险分层的新标志物。
- LOY相关风险由致命性心肌梗死驱动,提示需强化冠心病二级预防。
局限性
- 研究仅纳入男性参与者,结论不能外推至女性。
- 为观察性研究,LOY与心血管死亡的因果关系需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Acquired somatic mutations emerged as important drivers of adverse cardiovascular disease outcomes. Recently, mosaic loss of Y chromosome (LOY) in haematopoietic cells was identified to induce diffuse cardiac fibrosis in male mice. The aim of the present study was to determine the association between LOY and cardiovascular mortality in patients undergoing coronary angiography. METHODS: LOY was quantified in 1698 male participants of the LURIC study, who underwent coronary angiography, and its association with all-cause and cardiovascular mortality was determined. Furthermore, the interaction between LOY and inherited genetic susceptibility for cardiac fibrosis was assessed. RESULTS: The frequency of LOY steeply increased in male participants of LURIC at the age of 60 years. Loss of Y chromosome > 17% was associated with significantly higher all-cause [hazard ratio (HR) 1.41, 95% confidence interval (CI) 1.09-1.82] and cardiovascular mortality (HR 1.49, 95% CI 1.09-2.03), which was driven by a higher risk for fatal myocardial infarction (HR 2.65, 95% CI 1.46-4.81). Loss of Y chromosome > 17% was associated with a profibrotic and proinflammatory plasma protein expression profile as characterized by higher plasma levels of osteoprotegerin, matrix metalloproteinase-12, growth differentiation factor 15, heparin-binding EGF-like growth factor, and resistin. Genetic predisposition for lower myocardial fibrosis attenuated the association between LOY and cardiovascular mortality. Genome-wide methylation analyses identified differential methylation in 298 genes including ACTB, RPS5, WDR1, CD151, and ARAP1. Single-cell RNA sequencing further confirmed differential gene expression of 37 of these genes in LOY in peripheral blood mononuclear cells comprising a set of fibrosis-regulating genes including RPS5. RPS5 silencing in macrophages induced a paracrine induction of collagen expression in cardiac fibroblasts documenting a functional role in vitro. CONCLUSIONS: LOY represents an important independent risk factor for cardiovascular mortality in male patients with coronary artery disease. Targeting LOY may represent a sex-specific personalized medicine approach.
引用
- Weyrich M, Zewinger S, Sarakpi T, et al. Mosaic loss of Y chromosome and mortality after coronary angiography. Eur Heart J. 2025. PMID: 39935193. doi:10.1093/eurheartj/ehaf035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。